Managing the Elderly AML Patient: Clinical Issues and Strategies for Nurses

Last Modified: February 26, 2014

Share article


Co-Provided by:

AACME xme

Support for this activity has been made possible through an educational grant from:

Boehringer Ingelheim

Release date: February 25, 2014
Expiration date: February 25, 2015
Estimated time to complete: 1.25 hours
Activity URL: http://mediasite.med.upenn.edu/Mediasite/Play/5c536de92c5748ab99275da722e03bf21d
Post-Test: http://www.academycme.org/actID=13XM17

Activity Description

The incidence of acute myeloid leukemia (AML) is expected to increase as a result of several factors, including the aging of the population, a rise in secondary cases from environmental exposures, and wider recognition that low blood counts may be indicative of a bone marrow disorder rather than a normal consequence of aging. Lower survival rates in older patients with AML may be due to age, disease-related changes, aggressive chemotherapy, or treatment-associated adverse reactions.

The demographic shift occurring in the US during the next two decades underscores a critical need for continuing education for oncology nurses who will have an expanding role in the multidisciplinary management of older cancer patients. The complexity of caring for older adults with AML may place pressures upon the knowledge, competence, and performance of oncology practices. Oncology nurses and nurse practitioners must be able to think critically, analyze, reflect, problem-solve, and apply high-level knowledge that is evidence- and research-based to clinical interactions with patients who need their care.

Activity Faculty

Barbara Barnes Rogers, CRNP, MN, AOCN, ANP-BC
Adult Hematology-Oncology Nurse Practitioner
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Target Audience

This activity has been designed to meet the educational needs of oncology nurses and nurse practitioners involved in the care of patients with AML.

Learning Objectives

As a result of participating in the activity, learners should be better able to:

  • Identify variables that influence AML prognosis and AML treatment in elderly patients
  • Evaluate cognitive and physical functioning in elderly patients with AML
  • Describe common treatment-related side effects and strategies for side effect management, including those associated with novel and emerging treatment options for AML
  • Identify information and support resources for patients with AML and their caregivers

Accreditation and Credit Designation

Nursing Professionals

American Academy of CME, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

American Academy of CME, Inc. designates this educational activity for 1.25 contact hours (including 0.75 pharmacotherapeutic contact hours).

Disclosure Statement

According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosures are as follows:

Activity Faculty

Barbara Barnes Rogers, CRNP, MN, AOCN, ANP-BC: Promotional Speakers Bureau for Millennium, Seattle Genetics, and Teva

Independent Clinical Peer Reviewer

Brandi K. Swisher, MSN, CRNP, ACONP
Oncology Nurse Practitioner
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania

Ms. Swisher: Promotional Speakers Bureau for Celgene

Planning Committee

John JD Juchniewicz, MCIS, CCMEP, and Natalie Kirkwood, RN, BSN, JD, Lead Nurse Planner, American Academy of CME: No relevant financial relationships with any commercial interests.

Paul J. Miniter, MS, Elizabeth Paczolt, MD, Mindy Aratow, Pat McCollum, Excellence in Medical Education: No relevant financial relationships with any commercial interests.

This activity will not review off-label or investigational information.

Disclaimer

The opinions expressed in this educational activity are those of the faculty, and do not represent those of Academy, Excellence in Medical Education, or American Nurses Credentialing Council's Commission on Accreditation. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.

Method of Participation

There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CNE credit for your participation, please complete the post assessment (achieving a passing score of 70% or higher) and program evaluation. If requested, the activity ID is 13XM17. Your certificate can be printed immediately.

Hardware/Software Requirements

Participants will need to have Microsoft Silverlight to view the program. A free download is available at http://www.microsoft.com/silverlight/

Privacy

For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm

Contact

For any questions, please contact: CEServices@academycme.org

Copyright

© 2014. This CNE-certified activity is held as copyrighted © by American Academy of CME and Excellence in Medical Education. Through this notice, the Academy and Excellence in Medical Education grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

Proceed To Activity


News
Bedside Geriatric Assessment Feasible in Elderly With AML

Oct 28, 2011 - Inpatient bedside geriatric assessment is feasible, and is useful for identifying multiple geriatric impairments in elderly patients initiating chemotherapy for acute myelogenous leukemia, according to a study published in the October issue of the Journal of the American Geriatrics Society.



OncoLink Treatment Binder

Select the side effects and forms for your patient's treatment binder

Learn More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More